Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data

Osimertinib in EGFR-Mutated Lung Cancer: A Review of the Existing and Emerging Clinical Data

Chung-Shien Lee,1,2 Matthew Milone,3 Nagashree Seetharamu2 1Department of Clinical Health Professions, St. John’s University, Queens, NY, USA; 2Division of Medical Oncology and Hematology, Northwell Health Cancer Institute, Lake Success, NY, USA; 3Pharmacy Department, Long Island Jewish Medical Cent...

Full description

Bibliographic Details
Main Authors: Lee CS, Milone M, Seetharamu N
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:OncoTargets and Therapy
Subjects:
non-small cell lung cancer
epidermal growth factor receptor
tyrosine kinase inhibitor
osimertinib
Online Access:https://www.dovepress.com/osimertinib-in-egfr-mutated-lung-cancer-a-review-of-the-existing-and-e-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/osimertinib-in-egfr-mutated-lung-cancer-a-review-of-the-existing-and-e-peer-reviewed-fulltext-article-OTT

Similar Items